Tepezza 500 mg lyophilized powder for injection Images
Generic Name: teprotumumab
This medication has been identified as Tepezza 500 mg lyophilized powder for injection. It is supplied by Horizon Therapeutics USA, Inc.
Tepezza is used in the treatment of Thyroid Eye Disease and belongs to the drug class growth hormone receptor blockers. Tepezza 500 mg lyophilized powder for injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Tepezza
- Generic Name
- teprotumumab
- Strength
- 500 mg lyophilized powder for injection
- Availability
- Prescription only
- Drug Class
- Growth hormone receptor blockers
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Horizon Therapeutics USA, Inc.
- National Drug Code (NDC)
- 75987-0130
See also:
More about Tepezza (teprotumumab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (5)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Support group
- FDA approval history
- Drug class: growth hormone receptor blockers
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.